TABLE 2.
The clinicopathological features of 102 patients with cervical cancer
| Parameters | Number of patients | % | Parameters | Number of patients | % |
|---|---|---|---|---|---|
| Age (mean; range) | 44.7 ± 11.1; 24–78 | Parametrial invasion | |||
| ≤45 | 57 | 55.9 | + | 11 | 10.8 |
| >45 | 45 | 44.1 | − | 91 | 89.2 |
| Tumour size a (mean; range) | 2.9 ± 1.2; 0.3–5.5 | LNM c | |||
| ≤2 cm | 38 | 37.3 | + | 18 | 17.6 |
| >2 cm | 64 | 62.7 | − | 84 | 82.4 |
| FIGO stage | Positive margin | ||||
| Ia2+Ib1 | 49 | 48.0 | + | 4 | 3.9 |
| Ib2+IIa | 53 | 52.0 | − | ||
| Grade | Adjuvant radiotherapy | ||||
| 1 | 16 | 15.7 | + | 68 | 66.7 |
| 2+3 | 86 | 84.3 | − | 34 | 33.3 |
| LVSI b | Follow‐up time (month; range) | 64.6 ± 32.6;8–136 | |||
| + | 26 | 25.5 | Recurrence | 14 | 13.7 |
| − | 76 | 74.5 | Follow‐up period (month; range) | 26.1 ± 20.1; (5–90) | |
| Uterine isthmus involvement | Status at the last contact | ||||
| + | 4 | 3.9 | NED d | 88 | 86.3 |
| − | 98 | 96.1 | AWD e | 4 | 3.9 |
| Vaginal invasion | DOD f | 10 | 9.8 | ||
| + | 12 | 11.8 | 5‐RFS | 86.9 | |
| − | 90 | 88.2 | 5‐OS | 90.5 | |
a
Clinically measurable tumours only.
b
Lymphovascular space involvement.
c
Lymph node metastasis.
d
No evidence of disease.
e
Alive with disease.
f
Dead of disease.
g
Relapse‐free survival.
f
Overall survival.